Phoenix Group’s Shift Unveils High Yield Investment in Biotech
At Insider for Closed-End Funds (CEF), discovering high-yielding opportunities amidst market uncertainties is what we specialize in. This time, we spotlight an intriguing situation offering over 12% in dividends, a special case rooted not in the United States, but in…
